SC 13G Filing

Company

Tevogen Bio Holdings Inc.

Filed

March 4, 2024

Accession Number

0001123292-24-000067

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →